Skip to main content
Incidence of transfusion reactions: a multicenter study utilizing systematic active surveillance and expert adjudication.
- Author(s): Hendrickson, Jeanne E;
- Roubinian, Nareg H;
- Chowdhury, Dhuly;
- Brambilla, Don;
- Murphy, Edward L;
- Wu, Yanyun;
- Ness, Paul M;
- Gehrie, Eric A;
- Snyder, Edward L;
- George Hauser, R;
- Gottschall, Jerome L;
- Kleinman, Steve;
- Kakaiya, Ram;
- Strauss, Ronald G;
- National Heart, Lung, and Blood Institute (NHLBI) Recipient Epidemiology and Donor Evaluation Study (REDS-III)
- et al.
Published Web Locationhttp://onlinelibrary.wiley.com/doi/10.1111/trf.13730/abstract;jsessionid=0228F5CEBFF9984C5E17654E9A5AD3B0.f02t01
No data is associated with this publication.
BackgroundPrevalence estimates of the serious hazards of transfusion vary widely. We hypothesized that the current reporting infrastructure in the United States fails to capture many transfusion reactions and undertook a multicenter study using active surveillance, data review, and adjudication to test this hypothesis.
Study design and methodsA retrospective record review was completed for a random sample of 17% of all inpatient transfusion episodes over 6 months at four academic tertiary care hospitals, with an episode defined as all blood products released to a patient in 6 hours. Data were recorded by trained clinical research nurses, and serious reactions were adjudicated by a panel of transfusion medicine experts.
ResultsOf 4857 transfusion episodes investigated, 1.1% were associated with a serious reaction. Transfusion-associated circulatory overload was the most frequent serious reaction noted, being identified in 1% of transfusion episodes. Despite clinical notes describing a potential transfusion association in 59% of these cases, only 5.1% were reported to the transfusion service. Suspected transfusion-related acute lung injury/possible transfusion-related acute lung injury, anaphylactic, and hypotensive reactions were noted in 0.08, 0.02, and 0.02% of transfusion episodes, respectively. Minor reactions, including febrile nonhemolytic and allergic, were noted in 0.62 and 0.29% of transfusion episodes, respectively, with 30 and 50% reported to the transfusion service.
ConclusionUnderreporting of cardiopulmonary transfusion reactions is striking among academic, tertiary care hospitals. Complete and accurate reporting is essential to identify, define, establish pathogenesis, and mitigate/treat transfusion reactions. A better understanding of the failure to report may improve the accuracy of passive reporting systems.
Item not freely available? Link broken?Report a problem accessing this item